Abstract
Methotrexate (MTX) is a key agent for the treatment of acute lymphoblastic leukemia in children and the benefit of high-dose MTX is well established as it significantly increases cure rates and improves patients' prognosis. However, the determinants of MTX therapeutic effect are not clearly identified, although intracellular polyglutamation is essential. MTX, the monoglutamate form (MTXG₁) inhibits the dihydrofolate reductase (DHFR) implicated in the folate cycle. MTXG₁ is metabolized to active methotrexate polyglutamates (MTXPG) with sequential gamma-linkage of 2 to 6 glutamyl residues by the folylpolyglutamate synthetase (FPGS). Long chain MTXPG have higher affinity than MTX for the enzymes involved in de novo purine synthesis such as 5-aminoimidazole-4-carboxamide ribonucleotide transformylase (ATIC) and thymidilate synthase (TS), which results in a reinforcement of MTX inhibition. Thus, intracellular formation of MTXPG enhances the cytotoxic and antileukemic effect of MTX. Different pharmacogenetic polymorphisms contribute to interindividual variability in MTX response to treatment. In addition, pharmacokinetic interactions with 6-mercaptopurine (6-MP), frequently co-administered, have been reported. And factors affecting i...Continue Reading
Citations
Jan 10, 2014·PloS One·Yan LiuJian Zhang
Mar 22, 2014·Neurotoxicity Research·Tânia CapelôaAna P Silva
Jul 30, 2014·Molecular Nutrition & Food Research·Linda E KelemenNhu D Le
Nov 29, 2013·Drug Metabolism and Pharmacokinetics·Katsuhisa Inoue, Hiroaki Yuasa
Sep 24, 2016·BMC Cancer·C PetitJ P Vannier
Oct 27, 2017·Nanoscale Research Letters·Jinyu WangPeizhi Zhu
Mar 10, 2019·The FEBS Journal·Wenxi YuZan Shen
Aug 14, 2015·Hematology·Seham M Ragab, Eman A Badr
Apr 2, 2019·Current Pharmaceutical Design·Ya-Hui HuXing Ji
Feb 2, 2019·Current Drug Metabolism·Guillermo Gervasini, Sonia Mota-Zamorano
Nov 30, 2019·Medicina·Alma Mendoza-SantiagoGuadalupe García-Alcocer
Dec 30, 2017·Oncotarget·Amani MahbubNicola Jordan-Mahy
Aug 28, 2019·Oncology Letters·Jorge Organista-NavaMarco Antonio Leyva-Vázquez
Jun 25, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Duangjai PiwkhamBudsaba Rerkamnuaychoke
Jun 20, 2019·Journal of Cancer Research and Clinical Oncology·Somayeh Rahimi BabasheikhaliMahboubeh Mohammadi
Dec 27, 2019·Pediatric Blood & Cancer·Sebastiaan D T SassenRon A A Mathôt
Jul 10, 2019·Annual Review of Pharmacology and Toxicology·Laura B RamseySara L Van Driest
Jan 28, 2021·Pediatric Blood & Cancer·Yu ChengHong-Qiang Qiu
Aug 28, 2021·International Journal of Molecular Sciences·Ludovica Di MartinoErich Piovan